Transactional Delights

NOVEMBER 24, 2020

Following the November 2019 signing, covid hit and LVMH announced that it would not be able to close the deal by the agreement’s drop-dead date of November 24, 2020 [2] after the French Government sent a letter [3] to LVMH directing it to pause the deal until 2021. In this case, the leak worked in TIF’s favor. b) or Section 8.1(c)

M&A 40

M&A Mergers and Acquisitions IT Shares 40

Focus Investment Banking

JUNE 13, 2023

In addition to negotiated payments, providers can earn incentives for providing high-quality, efficient care. This Australian oncology platform, backed by PE giant KKR, acquired 21st Century Oncology in May 2020 in a deal valued at over $1 billion. Founded in 2007, publicly-traded TOI provides care to about 1.8

Hospitality 52

Hospitality Private Equity Healthcare Medical 52

Cooley M&A

JULY 9, 2021

However, the court’s January 2020 decision in the Panera appraisal proceeding provides a cautionary tale about the downside of prepaying the deal price for appraisal shares. Panera Bread was a publicly traded company that JAB Holdings B.V. took private in 2017 for $315/share. Contributors. Barbara Borden. Caitlin Gibson.

Mergers and Acquisitions 52

Mergers and Acquisitions Sale Shares Entertainment 52

Cooley M&A

OCTOBER 29, 2020

As reflected in Chart 1 , 102 SPAC IPOs have been announced this year as of September 18, 2020—almost double the number of SPAC IPOs in all of last year (and more than double the number of SPAC IPOs in 2018). A distinct feature of SPAC 3.0 is the increased frequency at which SPAC IPOs are occurring. Revisiting Governance Documentation.

M&A 52

M&A IPO Valuation Mergers and Acquisitions 52

Cooley M&A

SEPTEMBER 16, 2022

In addition, currently public dual-class companies with transfer provisions that do not contain clear carve outs for the delivery of voting agreements in the M&A context should discuss with their advisers the possibility of adopting “clear day” amendments to their charters to include these carve outs. Vote-down termination fee (i.e.,

M&A 59

M&A IPO Shares Mergers and Acquisitions 59

Cooley M&A

JANUARY 25, 2023

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. There are, however, reasons to think that M&A in the life sciences industry is on the upswing.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

JANUARY 20, 2022

Although the COVID-19 pandemic that defined 2020 continued to shape much of the life sciences industry in 2021, the way that it did was markedly different. A healthy 90 biopharma M&A transactions were announced in 2021 (compared to 69 in 2020 and 70 in 2019, the most transactions since 2016). As we noted in our 2020 year?end

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40